Welcome to our dedicated page for Branded Legacy news (Ticker: BLEG), a resource for investors and traders seeking the latest updates and insights on Branded Legacy stock.
Branded Legacy, Inc. (BLEG) delivers innovative biotech solutions through pharmaceutical research, natural product development, and strategic acquisitions. This news hub provides investors and industry stakeholders with verified updates on the company's progress in FDA clinical trials, market expansions, and technological advancements.
Access real-time announcements covering earnings reports, partnership agreements, product launches, and regulatory milestones. Our curated collection ensures transparent tracking of BLEG's initiatives in plant-based pharmaceuticals, advanced extraction techniques, and wellness product innovation.
Key updates include developments from the Sycamore BioPharma acquisition, white-label partnership expansions, and advancements in botanical extraction technology. Stay informed about operational milestones that demonstrate the company's commitment to quality manufacturing and scientific rigor.
Bookmark this page for streamlined access to Branded Legacy's evolving position in the biotech sector. Check regularly for essential updates impacting investment decisions and industry analysis.
Branded Legacy, Inc. (OTCQB: BLEG) has relocated its corporate headquarters to Charlotte, North Carolina, effective September 1, 2022. The new address is 227 W 4th Street, Unit 108, Charlotte, NC 28202. This move is significant for the company's growth, particularly with its leadership residing in the area. The company reports strong demand for its cannabinoid-infused products, having sold through its latest inventory of gummies and planning to expand flavors and product lines, including disposable vapes.
Branded Legacy, Inc. (OTCQB: BLEG) has successfully sold its current inventory of Delta 8 Gummies, seeing increased demand and larger reorder volumes. Sales have surged as the company expands into North Carolina retail locations. To meet demand, Branded Legacy will produce larger quantities of gummies and is planning to introduce additional flavors and disposable vapes. Confidence in the Spikes CBDX brand continues to grow among customers, boosting future growth prospects.
Branded Legacy, Inc. (OTCQB: BLEG) has completed the acquisition of Magic 1 Promotions, LLC, a company focused on solar energy and water purification. This strategic move is expected to boost revenue by over $450,000 and aligns with Branded Legacy's expansion into clean energy. Magic 1 Promotions generated approximately $320,000 in revenue in the first eight months of 2022 and aims to exceed $1,000,000 in 2023. The acquisition will be integrated under the wholly-owned subsidiary, Versatile Industries, LLC, enhancing shareholder value through future dividends.
Branded Legacy, Inc. (OTCQB: BLEG) announced a letter of intent to acquire Magic 1 Promotions, LLC, a company specializing in solar and water purification solutions. This acquisition is expected to add approximately $250,000 in revenue to Branded Legacy. Currently cash flow positive, Magic 1 Promotions aims to achieve over $1,000,000 in revenue within the next year. The acquisition will be executed through Branded Legacy's subsidiary, Versatile Industries, LLC, as part of a strategy to expand into the clean energy sector.
Branded Legacy, Inc. (OTCQB: BLEG) has announced its partnership with Treezee Smoke Shop and CBD Marketplace, set to launch soon. This collaboration is aimed at enhancing exposure for Branded Legacy's cannabinoid-infused products, including CBD topicals and edibles. The partnership enables fast, reliable shipping from licensed CBD businesses. Additionally, the company has hired two new sales representatives in North Carolina and Michigan to boost sales efforts. Chairman Brandon Spikes expressed optimism about reaching new audiences and achieving significant traction for shareholders.
Branded Legacy, Inc. (BLEG) has received Board approval for a 33.33% reduction in its authorized shares, decreasing them by 300 million to 600 million shares. The company aims to enhance shareholder value by improving its share structure and reducing debt. In 2022, BLEG reduced liabilities by $436,119 and outstanding common shares by 202 million. Current issued shares stand at 236,982,816. Brandon Spikes, the chairman, emphasized the commitment to shareholder success.
Branded Legacy (OTCQB: BLEG) announced on Aug. 19, 2022, that its Board of Directors unanimously decided not to conduct a reverse stock split for at least 12 months. Additionally, the board plans to vote on reducing the authorized common shares by 300 million, bringing the total down to 600 million. Chairman Brandon Spikes emphasized building shareholder confidence through these actions, aiming for long-term value creation. The board's resolutions will be available on OTC Markets soon.
Branded Legacy Achieves Current Status on OTC Markets
Branded Legacy, Inc. (OTCQB: BLEG) announced its compliance with OTC Markets, successfully removing its Yield Sign. The company confirms its Current Information status, with all disclosures updated as of June 30, 2022. Chairman Brandon Spikes emphasized their commitment to exceed OTC compliance standards, enhancing shareholder confidence. Additionally, Branded Legacy has canceled 40 million shares in August, reducing total shares to approximately 237 million, supporting a stronger stock position.
Branded Legacy has successfully canceled 202 million common shares in August 2022 to improve its share structure and enhance shareholder value. The company's recent cancellation of 40 million shares brings the issued and outstanding total down to 236,982,816. CEO Jermain Strong expressed optimism about the company's ongoing share buyback program, aiming to further boost shareholder returns. The company specializes in cannabinoid-infused products, targeting health and wellness sectors.
Branded Legacy, Inc. (OTCQB: BLEG) announced the removal of $436,119 in debt from its balance sheet in 2022, reducing liabilities by $112,839 recently. The company's strategic move aims to improve its financial health, making the share structure more attractive to investors and expediting its journey towards cash flow positivity. CEO Jermain Strong expressed optimism about these developments, highlighting the potential for significant growth and added shareholder value.